RED DEER, AB, March 10, 2021 /CNW/ – CanadaBis Capital Inc’s 100% owned subsidiary, Stigma Grow, is pleased to announce that the Ontario Cannabis Store (OCS), Ontario’s only online retailer and wholesaler of legal recreational cannabis in the province, has entered into a supply agreement with a selection of Stigma Grow products directly to their growing list of retailers and online shoppers as early as April 2021.
Stigma Grow is thrilled to begin bringing their live-resin, high-terpene, full-spectrum extracts (HCFSE) into the province, starting with their Black NGL and White NGL vape cartridges. Offering true, full-spectrum, hydrocarbon butane quality extracts within a vape category currently dominated by distillates.
“We are excited to finally bring our lineup of live-resin concentrates to a province who has long awaited the type of quality, potency and pricing that we can bring to the 2.0 product space,” says Travis McIntyre, CEO of CanadaBis Capital Inc. “For the past few months, we’ve leveraged our relationships and in-house expertise to help lead the growth of the concentrate’s category across Canada – ensuring our brands remain engaging and educational, while our products continue to push for high-quality and fair pricing in everything we offer. It appears the word is getting out all across Canada.”
The addition of Ontario to the growing list of provinces now selling Stigma Grow products comes just a few weeks after the successfully launch of Stigma Grow’s entire product lineup across British Columbia including their newly launched, high-value concentrates brand Dab Bods, and their popular lineup of Chapter 1 Badders and Live-Resin Budders.
Now available and in-demand across BC, Alberta, Saskatchewan, Manitoba, Ontario and Nova Scotia, Stigma Grow has increased their production volume capacity significantly to meet what they believe will be a growing demand for unique and popular products, as well as to prepare and position their products for future global markets.
About Stigma Grow
Stigma Grow is a cutting-edge cannabis cultivation and extraction company positioned advantageously to meet the unmet market demands and stigmas within the legal cannabis industry head on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada’s legal cannabis industry.
About CanadaBis Capital Inc.
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to statements with respect to our business and operations; timing of the Company’s profitability; the demand and sales volumes of the Company’s products, and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions including: the ability of the Company’s products to compete with the pricing and product availability on the black-market; the market demand for the Company’s products; and assumptions concerning the Company’s competitive advantages. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; ability to sustain or create a demand for a product; requirement for further capital; delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Company’s continuous disclosure on SEDAR at www.sedar.com. There can be n no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FORWARD LOOKING STATEMENTS
THIS NEWS RELEASE CONTAINS “FORWARD-LOOKING INFORMATION” WITHIN THE MEANING OF APPLICABLE SECURITIES LAWS INCLUDING STATEMENTS REGARDING THE FUTURE PURCHASE ORDERS, THE DEMAND FOR EMBARK’S PRODUCTS, TIMING FOR THE SALE OF ADDITIONAL PRODUCTS, THE SUCCESS OF EMBARK’S PRODUCTS IN THE MARKET AND THE ABILITY OF EMBARK TO SUCCESSFULLY EXECUTE ITS BUSINESS PLAN. ALTHOUGH EMBARK BELIEVES IN LIGHT OF THE ESTIMATES BY MANAGEMENT, CURRENT CONDITIONS AND EXPECTED FUTURE DEVELOPMENTS AND OTHER FACTORS, THAT THE EXPECTATIONS REFLECTED IN THIS FORWARD-LOOKING INFORMATION ARE REASONABLE, UNDUE RELIANCE SHOULD NOT BE PLACED ON THEM. ACCORDINGLY, EMBARK CAN GIVE NO ASSURANCE THAT THEY WILL PROVE TO BE CORRECT. ACTUAL RESULTS AND DEVELOPMENTS MAY DIFFER MATERIALLY FROM THOSE CONTEMPLATED BY THESE STATEMENTS DEPENDING ON, AMONG OTHER THINGS, CHANGES IN ECONOMIC CONDITIONS OR FINANCIAL MARKETS; REGULATORY DELAYS; INCREASES IN COSTS; LITIGATION; LEGISLATIVE, ENVIRONMENTAL AND OTHER JUDICIAL, REGULATORY, POLITICAL AND COMPETITIVE DEVELOPMENTS; AND TECHNOLOGICAL OR OPERATIONAL DIFFICULTIES. THIS LIST IS NOT EXHAUSTIVE OF THE FACTORS THAT MAY AFFECT OUR FORWARD-LOOKING INFORMATION. THE STATEMENTS IN THIS PRESS RELEASE ARE MADE AS OF THE DATE OF THIS RELEASE. THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE REFLECTED IN THE FORWARD-LOOKING STATEMENTS UNLESS AND UNTIL REQUIRED BY SECURITIES LAWS APPLICABLE TO THE COMPANY.
SOURCE CanadaBis Capital Inc.
For further information: on CanadaBis Capital, 1998643 (Stigma Grow), or INDICAtive Collection please visit www.canadabis.com, www.stigmagrow.ca, www.indicativecollection.ca or contact: Investor Relations Info@CanadaBis.com 1-888-STIGMA1